Munich, Germany

Vic Ilag

This inventor holds 2 USPTO granted patents. Top assignee: Morphosys Ag. Active years: 2003-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vic Ilag. Retrieved from https://idiyas.com/inventor/vic-ilag

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 50.0

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 2003-2006

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Vic Ilag: Innovator in Nucleic Acid Sequence Identification

Introduction

Vic Ilag is a prominent inventor based in Munich, Germany. He has made significant contributions to the field of biotechnology, particularly in the identification of nucleic acid sequences. With a total of 2 patents, his work has the potential to impact various applications in genetic research and development.

Latest Patents

Vic Ilag's latest patents focus on innovative methods for identifying nucleic acid sequences encoding members of a multimeric (poly)peptide complex. The first patent describes a method and phage for this identification by screening for polyphage particles. This invention not only outlines the methods but also discusses the products and their uses for identifying nucleic acid sequences effectively.

Career Highlights

Vic Ilag is currently associated with Morphosys AG, a leading biotechnology company. His work at Morphosys AG has allowed him to explore and develop groundbreaking technologies in the field of molecular biology. His contributions have been instrumental in advancing the understanding of complex peptide interactions.

Collaborations

Vic has collaborated with notable colleagues such as Fritz Rudert and Liming Ge. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Vic Ilag's work in the identification of nucleic acid sequences showcases his dedication to advancing biotechnology. His patents and collaborations reflect his commitment to innovation in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…